Skip to main content
Log in

Miricorilant provides significant benefit for olanzapine-associated weight gain

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Corcept Therapeutics.

Reference

  • Hunt HJ, et al. Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study. Journal of Clinical Psychopharmacology : 6 Aug 2021. Available from: URL: http://doi.org/10.1097/JCP.0000000000001470

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miricorilant provides significant benefit for olanzapine-associated weight gain. Reactions Weekly 1870, 8 (2021). https://doi.org/10.1007/s40278-021-01218-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01218-1

Navigation